Cargando…
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial
BACKGROUND: Human papilloma viruses (HPVs) infect squamous epithelial cells and form verrucous lesions, or warts. Besides the psychosocial problems caused by the disfiguring warts, a subset of HPVs can be the primary etiologic agent for malignancies such as cervical cancer. However, there is no cura...
Autores principales: | Nomura, Takashi, Sumi, Eriko, Egawa, Gyohei, Nakajima, Saeko, Toichi, Eiko, Uozumi, Ryuji, Tada, Harue, Nakagawa, Takayuki, Hagiwara, Masatoshi, Kabashima, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688352/ https://www.ncbi.nlm.nih.gov/pubmed/31399147 http://dx.doi.org/10.1186/s13063-019-3570-6 |
Ejemplares similares
-
Safety and Efficacy of FIT039 for Verruca Vulgaris: A Placebo-Controlled, Phase I/II Randomized Controlled Trial
por: Nomura, Takashi, et al.
Publicado: (2021) -
Safety and Plasma Concentrations of a Cyclin-dependent Kinase 9 (CDK9) Inhibitor, FIT039, Administered by a Single Adhesive Skin Patch Applied on Normal Skin and Cutaneous Warts
por: Sumi, Eriko, et al.
Publicado: (2018) -
Application of the CDK9 inhibitor FIT-039 for the treatment of KSHV-associated malignancy
por: Sakamoto, Tetsunori, et al.
Publicado: (2023) -
TREATMENT OF VERRUCA VULGARIS IN TRADITIONAL MEDICINE
por: Muršić, Ivanka, et al.
Publicado: (2020) -
Verruca Vulgaris and Seborrheic Keratosis Exacerbated by Immunosuppression
por: Iida, Shohei, et al.
Publicado: (2020)